Patents by Inventor Michael Riddell

Michael Riddell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of exercise-induced hypoglycemia in type 1 and insulin using type 2 diabetes
    Patent number: 12514907
    Abstract: Certain embodiments are directed to methods for treating, ameliorating, or preventing exercise-induced or exercise-associated hypoglycemia comprising administration to a subject in need thereof a formulation(s) of glucagon or glucagon analog in an amount effective to treat, ameliorate, or prevent the condition. The subject can be administered a glucagon or a glucagon analog composition 1, 5, 10, 15 to 20, 25, 30 minutes prior to initiation of exercise.
    Type: Grant
    Filed: July 24, 2023
    Date of Patent: January 6, 2026
    Assignee: Xeris Pharmaceuticals, Inc.
    Inventors: Steven Prestrelski, Brett Newswanger, Martin Cummins, Michael Riddell
  • TREATMENT OF EXERCISE-INDUCED HYPOGLYCEMIA IN TYPE 1 AND INSULIN USING TYPE 2 DIABETES
    Publication number: 20240016898
    Abstract: Certain embodiments are directed to methods for treating, ameliorating, or preventing exercise-induced or exercise-associated hypoglycemia comprising administration to a subject in need thereof a formulation(s) of glucagon or glucagon analog in an amount effective to treat, ameliorate, or prevent the condition. The subject can be administered a glucagon or a glucagon analog composition 1, 5, 10, 15 to 20, 25, 30 minutes prior to initiation of exercise.
    Type: Application
    Filed: July 24, 2023
    Publication date: January 18, 2024
    Applicant: Xeris Pharmaceuticals, Inc.
    Inventors: Steven PRESTRELSKI, Brett NEWSWANGER, Martin CUMMINS, Michael RIDDELL
  • TREATMENT OF EXERCISE-INDUCED HYPOGLYCEMIA IN TYPE 1 AND INSULIN USING TYPE 2 DIABETES
    Publication number: 20210008170
    Abstract: Certain embodiments are directed to methods for treating, ameliorating, or preventing exercise-induced or exercise-associated hypoglycemia comprising administration to a subject in need thereof a formulation(s) of glucagon or glucagon analog in an amount effective to treat, ameliorate, or prevent the condition. The subject can be administered a glucagon or a glucagon analog composition 1, 5, 10, 15 to 20, 25, 30 minutes prior to initiation of exercise.
    Type: Application
    Filed: December 21, 2018
    Publication date: January 14, 2021
    Applicant: XERIS PHARMACEUTICALS, INC.
    Inventors: Steven PRESTRELSKI, Brett NEWSWANGER, Martin CUMMINS, Michael RIDDELL
  • Fuel pump system
    Publication number: 20050284448
    Abstract: A fuel pump system includes a fuel pump having a direct current motor for driving a pumping element to deliver fuel to an engine at a variable rate. A pulse width modulated controller is electrically communicated with the motor for varying the speed thereof, thereby enabling the fuel pump to deliver the fuel to the engine at the variable rate. The controller includes a first switch in series with the motor and a second switch in parallel across the motor. In a motor-off cycle, control electronics connected to the switches deactivate the first switch and activate the second switch to commutate the motor. In a motor-on cycle, the control electronics deactivate the second switch and activate the first switch to power the motor.
    Type: Application
    Filed: June 15, 2005
    Publication date: December 29, 2005
    Inventors: John Forgue, Matthias Henschel, Michael Riddell, Peter Schreuder